Agile Therapeutics(AGRX)2021-01-29 07:42
$Agile Therapeutics(AGRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-21-008901 Size: 7 KB 网页链接查看全文
Agile Therapeutics(AGRX)2021-02-03 04:34
$Agile Therapeutics(AGRX)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000834237-21-006836 Act: 34 Size: 13 KB 网页链接查看全文
Agile Therapeutics(AGRX)2021-01-29 07:42
$Agile Therapeutics(AGRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-21-008906 Size: 5 KB 网页链接查看全文
Agile Therapeutics(AGRX)2021-01-29 07:30
$Agile Therapeutics(AGRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-21-008897 Size: 5 KB 网页链接查看全文
Agile Therapeutics(AGRX)2021-01-29 07:36
$Agile Therapeutics(AGRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-21-008898 Size: 5 KB 网页链接查看全文
逍遥投资派2023-05-13 19:38
$Agile Therapeutics(AGRX)$ 2020年产生少量营收,2022年增长到1100万,营业利润和净利润继续大幅亏损,目前缺乏投资价值。查看全文
反贾骗联盟首席2022-07-11 14:34
$Agile Therapeutics(AGRX)$ $Evofem Biosciences(EVFM)$ 这两个标的一起来看,信息比较稀少,需要仔细看IR和SEC的内容,方向了解还比较少,是个新的有潜力的细分方向查看全文
来源:格隆汇 格隆汇6月14日丨Agile Therapeutics(AGRX.US)盘前涨35.65%,报4.87美元。Agile Therapeutics宣布与VitaCare处方服务公司达成新协议,以扩大Twirla的使用范围,推动公司2023年实现净收入2500万至30... 网页链接
$Agile Therapeutics(AGRX)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001558370-24-004262 Act: 34 Size: 10 MB 网页链接
$Agile Therapeutics(AGRX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001558370-24-004174 Act: 34 Size: 503 KB 网页链接
$Agile Therapeutics(AGRX)$ 8-K Current report, items 3.01, 8.01, and 9.01 Accession Number: 0001558370-24-003854 Act: 34 Size: 207 KB 网页链接
$Agile Therapeutics(AGRX)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001558370-24-003246 Act: 34 Size: 192 KB 网页链接
$Agile Therapeutics(AGRX)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-24-027083 Act: 33 Size: 22 KB 网页链接
$Agile Therapeutics(AGRX)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-24-027084 Act: 33 Size: 21 KB 网页链接
$Agile Therapeutics(AGRX)$ 8-K Current report, items 1.01, 3.02, 3.03, 8.01, and 9.01 Accession Number: 0001558370-24-001624 Act: 34 Size: 803 KB 网页链接
$Agile Therapeutics(AGRX)$ 8-K Current report, items 1.01, 2.02, 8.01, and 9.01 Accession Number: 0001558370-24-001247 Act: 34 Size: 250 KB 网页链接
$Agile Therapeutics(AGRX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000929638-24-000556 Act: 34 Size: 76 KB 网页链接
$Agile Therapeutics(AGRX)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001104659-24-011653 Act: 33 Size: 32 MB 网页链接